LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Jai Radhe Sales
03 1Vamsi Labs
04 1HRV Global Life Sciences
05 1Octavius Pharma Pvt. Ltd
06 1Tagoor Laboratories
07 1Amino Chemicals
08 1Changzhou Siyao Pharmaceuticals
09 1Dipharma
10 1Fleming Laboratories
11 1Grupo Juste
12 1Neha Chemicals
13 1Olon S.p.A
14 1R L Fine Chem
15 1Siegfried AG
16 1Sifavitor srl
17 1Sneha Medicare Pvt Ltd
18 1Stason Pharmaceuticals, Inc.
19 1Unipex
20 4Vasudha Pharma Chem
01 1China
02 1France
03 13India
04 3Italy
05 1Malta
06 1Spain
07 1Switzerland
08 2U.S.A
01 3Active
02 2Inactive
03 18Blank
01 1Valid
02 22Blank
01 1220MF10143
02 1220MF10221
03 21Blank
01 2WC-0070
02 1WC-0183
03 1WC-0183nA2
04 1WC-0229
05 1WC-0445
06 17Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-28
Pay. Date : 2012-12-19
DMF Number : 25456
Submission : 2011-10-10
Status : Active
Type : II
Date of Issue : 2022-06-15
Valid Till : 2025-07-14
Written Confirmation Number : WC-0183nA2
Address of the Firm :
NDC Package Code : 66577-014
Start Marketing Date : 2018-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-15
Pay. Date : 2012-11-26
DMF Number : 3293
Submission : 1978-09-13
Status : Active
Type : II
Registration Number : 220MF10143
Registrant's Address : Strada Rivoltana Km 6/7 20053 Rodano Milano Italy
Initial Date of Registration : 2008-06-10
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-23
Pay. Date : 2013-04-09
DMF Number : 3524
Submission : 1979-02-08
Status : Active
Type : II
Registration Number : 220MF10221
Registrant's Address : Via Bissone, 5, 20021-Baranzate, Milano, Italy
Initial Date of Registration : 2008-11-04
Latest Date of Registration : --
NDC Package Code : 46438-0036
Start Marketing Date : 1980-01-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3382
Submission : 1978-11-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17364
Submission : 2004-02-20
Status : Inactive
Type : II
Date of Issue : 2022-08-16
Valid Till : 2025-08-13
Written Confirmation Number : WC-0229
Address of the Firm :
Date of Issue : 2022-06-14
Valid Till : 2025-07-04
Written Confirmation Number : WC-0070
Address of the Firm :
NDC Package Code : 66577-014
Start Marketing Date : 2018-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-06-14
Valid Till : 2025-07-04
Written Confirmation Number : WC-0070
Address of the Firm :
NDC Package Code : 66577-014
Start Marketing Date : 2018-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0183
Address of the Firm :
NDC Package Code : 66577-014
Start Marketing Date : 2018-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : R1-CEP 2014-049 - Rev 01
Issue Date : 2022-01-25
Type : Chemical
Substance Number : 817
Status : Valid
NDC Package Code : 17337-0508
Start Marketing Date : 2017-04-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2019-07-29
Valid Till : 2022-07-29
Written Confirmation Number : WC-0445
Address of the Firm :
NDC Package Code : 71554-003
Start Marketing Date : 2019-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Cyproheptadine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyproheptadine Hydrochloride, including repackagers and relabelers. The FDA regulates Cyproheptadine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyproheptadine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyproheptadine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyproheptadine Hydrochloride supplier is an individual or a company that provides Cyproheptadine Hydrochloride active pharmaceutical ingredient (API) or Cyproheptadine Hydrochloride finished formulations upon request. The Cyproheptadine Hydrochloride suppliers may include Cyproheptadine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Cyproheptadine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 20 companies offering Cyproheptadine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?